Condition

Breast Tumors

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 27 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials27

Recruiting4

Common interventions25

Lead sponsors shown15

Clinical trials

27 shown

HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor SurgeryNCT07209020 · 2025-05-20

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyNCT06805812 · 2023-05-01

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyNCT05582499 · 2022-11-01

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerNCT01042379 · 2010-03-01

Clinical Study of 18F-FAPI-RGD in Breast TumorsNCT05976620 · 2023-06-20

Therapeutic Dose Monitoring (TDM) of TamoxifenNCT05133674 · 2022-04-04

A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast CancerNCT05584644 · 2021-05-24

Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers AnalysisNCT04132960 · 2019-10-21

Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant TreatmentNCT02891681 · 2016-11-29

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerNCT02187991 · 2015-02-12

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast CancerNCT02296801 · 2015-01-01

Use of Metformin to Reduce Cardiac Toxicity in Breast CancerNCT02472353 · 2014-07-01

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast CancerNCT01980823 · 2013-10-01

Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesNCT02225470 · 2013-09-26

Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than LevobupivacaineNCT02004834 · 2013-08-01

ACTIVE_NOT_RECRUITING

Simulated Screening Study for Breast ImagingNCT01807754 · 2012-12-01

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerNCT01498588 · 2011-11-01

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast TumorsNCT01218529 · 2010-10-01

Re-expression of ER in Triple Negative Breast CancersNCT01194908 · 2010-07-01

Study of Pralatrexate in Female Patients With Previously-treated Breast CancerNCT01118624 · 2010-03-01

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerNCT01271738 · 2009-09-01

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerNCT00807859 · 2009-03-09

Biomarker Study of Breast TumorsNCT00941408 · 2009-03-01

QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerNCT00626106 · 2008-03-27

A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast CancerNCT00356681 · 2006-12-01

Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or MalignantNCT00639171 · 2005-11-01

A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast LesionsNCT00243698 · 2004-05-01

Common interventions

Leading sponsors

Emory University 3 Amgen 2 Acrotech Biopharma Inc. 1 Avera McKennan Hospital & University Health Center 1 Columbia University 1 Eisai Co., Ltd. 1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1 Fudan University 1 Hellenic Cooperative Oncology Group 1 Karolinska University Hospital 1 Maxigen Biotech Inc. 1 NantCell, Inc. 1 National University Hospital, Singapore 1 NSABP Foundation Inc 1 Pfizer 1

Trial status mix

COMPLETED16

RECRUITING4

TERMINATED4

UNKNOWN2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE213

NA4

PHASE12

EARLY_PHASE11

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.